Background: Functional outcome scores provide valuable data, yet they can be burdensome to patients and require significant resources to administer. The Knee injury and Osteoarthritis Outcome Score (KOOS) is a knee-specific patient-reported outcome measure (PROM) and is validated for anterior cruciate ligament (ACL) reconstruction outcomes. The KOOS requires 42 questions in 5 subscales. We utilized a machine learning (ML) algorithm to determine whether the number of questions and the resultant burden to complete the survey can be lowered in a subset (activities of daily living; ADL) of KOOS, yet still provide identical data.
Anterior cruciate ligament (ACL) rupture is a common sports-related injury that, if untreated, can result in continued instability, secondary meniscal tears, and eventual progression toward development of osteoarthritis. 10, 16, 17 ACL reconstruction is the standard treatment for ACL ruptures to restore knee biomechanics, allowing for the resumption of prior physical activities and improved quality of life. 8 To better measure a patient's outcome after ACL reconstruction, surgeons have employed the use of patient-reported outcome measures (PROMs).
The Knee injury and Osteoarthritis Outcome Score (KOOS) is one such knee-specific questionnaire developed to follow patients' functional outcomes after the inciting trauma as well as their recovery postoperatively. 15 Since its initial publication in 1998, the KOOS scale has been extensively used to describe functional outcomes related to knee injuries. 16 Its initial validation study for the English language version of the test was performed using patients undergoing ACL reconstruction. For the past 2 decades, many studies 4, 12, 13 have been designed using the KOOS scale as their validated foundation to quantify patient-reported outcomes after ACL reconstruction. KOOS includes 42 questions in 5 distinctly scored subscales, including Pain (9 questions), other Symptoms (7 questions), Activities of Daily Living (ADL) (17 questions), Function in Sport and Recreation (5 questions), and knee-related Quality of Life (4 questions). 15 While PROMs provide meaningful data, they can be time consuming for patients to complete and resource intensive for practices to administer. The KOOS scale has been validated, but are all of the contained questions necessary to obtain equally meaningful data? Could a streamlined questionnaire provide the same quality data yet minimize the burden of administration and completion? Such improvements in PROMs could lead to increased compliance, better outcome reporting in all practice settings, and improved understanding of patient outcomes.
The goal of this study was to identify a subset of essential questions that can accurately identify outcomes utilizing a machine learning (ML) algorithm. ML is a field of study that uses computer algorithms and statistics to identify complex trends and patterns in the data that may not be easily discernible by humans. 3 ML uses data to build empirical/statistical models to describe the behavior of a system. In this study, just the KOOS ADL subscale was used rather than the entire questionnaire for "proof of concept." We hypothesized that fewer questions are actually needed compared with what is currently provided to predict the KOOS ADL score with high accuracy in patients being treated for ACL ruptures.
METHODS

Data Source
Data for analysis were obtained from the Surgical Outcome System (SOS) global registry, an international patientreported outcome database maintained by Arthrex. No institutional review board (IRB) approval was required, as SOS global registry is IRB approved and adheres to Health Insurance Portability and Accountability Act (HIPAA) regulations. All SOS global registry users have access to the shared deidentified data.
All patients who underwent ACL reconstruction between 2010 and 2018, had completed the pre-and postsurgery KOOS ADL survey, and had at least 3 months of follow-up data were included. Patients with missing KOOS ADL survey responses were omitted from the data set. Patient characteristics and procedure-related information such as sex, age at treatment, race and ethnicity, and year of operation were also obtained.
Data Preparation and Model Building
Data processing, analysis, and ML model building were performed using commercially available RStudio. The charts for data analysis were obtained using the "ggplot2" package in RStudio. Categorical Boosting (CatBoost) ML models were built using the "CatBoost" package. 5 CatBoost is a gradient boosting tool kit, which allows for ordered boosting-a modification of a standard gradient boosting algorithm-that avoids target leakage, and uses a new algorithm for processing categorical features. 6, 14 The data were randomly split into 2 subsets: a training set with 80% data and a test set with the remaining 20% data. ML models to predict KOOS ADL (with survey responses as predictors) were built using the training data set. Several hyperparameter values were evaluated to identify the "best" model. The choice of the best model was based on minimizing the root mean square error. The performance of the best model was then evaluated on the test data set to gauge its performance on this blind, heldout data set. The hyperparameters used for the final model were as follows:
One of the outcomes of the CatBoost model is the relative importance of each of the input features (ie, KOOS ADL questions) in explaining the overall prediction. The importance of each feature is determined by calculating the difference in the error with and without that feature in the model. A higher error indicates that the feature is more important, while a lower error indicates less importance. Each of the input features is ranked based on this calculation to get the relative feature importance. A predetermined R 2 value of 0.95 was chosen, as the suggested minimal perceptible clinical improvement in KOOS is 8 to 10 points, and explaining 95% of the variance in KOOS would cover this range of 8 to 10 points adequately. 15 
Statistical Analysis
Statistical analysis was performed using RStudio (v 3.4.2). Data for presurgery versus 3 months postsurgery were reported as mean ± SD for the full KOOS ADL. These values were then compared with the streamlined KOOS ADL values, determining the R 2 value. A Welch 2-sample t test was performed, and P < .05 was considered statistically significant.
RESULTS
A total of 6185 patients who underwent ACL reconstruction were identified. Of these patients, 2525 between the ages 16 and 50 years had completed KOOS ADL scores presurgically and 3 months postoperatively. These patients were included in our analysis.
The data set with compliant presurgery responses consisted of 1309 (51.84%) males and 1216 (48.16%) females ( Figure 1) . The mean age of the included patients was 29 years (range, 16-50 years) ( Figure 2) .
The mean ± SD presurgery and 3-month postsurgery KOOS ADL scores were 73.96 ± 19.31 and 86.66 ± 12.36, respectively. A Welch 2-sample t test indicated a statistically significant difference (P < 2.2e-16) in the means for presurgery and 3-month postsurgery KOOS ADL score (Figure 3 ). Since the presurgery and 3-month postsurgery KOOS ADL score distributions were statistically different, the 2 distributions were analyzed separately.
The scatter plot of CatBoost model predictions using all 17 questions of the KOOS ADL questionnaire versus the actual scores for the test data set (n ¼ 505) predicted KOOS ADL scores with high accuracy (R 2 ¼ 0.99) (Figure 4 ), proving the validity of the initial model.
Interestingly, using the CatBoost model, it was determined that only 6 of the 17 questions (descending stairs, ascending stairs, standing, walking on flat surface, putting 
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Streamlining the KOOS ADL Using Machine Learning 3 on socks/stockings, and getting on/off toilet) ( Table 1) were needed to achieve an accuracy in KOOS ADL scores similar to that of the full questionnaire ( Figure 5 ). The specific 6 questions were chosen based on the CatBoost model feature importance (from the training data set) and the ease of quantitatively measuring the response. As shown in Figure 5 , the validity of using these 6 questions to predict the KOOS ADL score was confirmed by predicting the KOOS ADL score on the randomly chosen 20% test data set, which was not used in building the model.
DISCUSSION
Functional outcome metrics remain a relatively new yet important public health advancement. 11 For much of the history of medicine, clinical success has been defined by the absence of complications or by simple clinical parameters such as range of motion. Despite the validity and usefulness from a research perspective, PROMs pose certain issues, including lengthy questionnaires, redundant questions, and narrow scope, thus limiting their utilization in many practice settings. 17 To circumvent these issues, the Patient-Reported Outcome Measurement Information System (PROMIS) was developed. Implementation of PROMIS led to a significant improvement in the measurement characteristics and a reduction in patient and administrative burden. However, this system was validated only in patients with orthopaedic disorders related to foot and ankle, upper extremities, and spine. 1 Thus, in this study, we focused on using an ML algorithm to identify the important parts of a knee-specific PROM, the KOOS ADL subscale, that has been validated for ACL reconstruction outcomes. ML adoption is still preliminary in the field of orthopaedics, although in other medical specialties, ML models have been developed and validated to outperform human specialists. 2, 7, 9 Nonetheless, the number of publications discussing utilization of ML in orthopaedics since 2000 has increased, indicating its value and potential acceptance in real-world settings. 3 The results confirmed the study hypothesis and demonstrated that only 6 questions-descending stairs, ascending stairs, standing, walking on flat surface, putting on socks/ stockings, and getting on/off toilet-can reliably predict outcomes with similar accuracy compared with the original 17-question subscale. The use of this abbreviated survey may result in a better patient-reporting experience and compliance while still providing quality data.
Despite encouraging results, this study has several limitations. First, the data were limited to include patients with follow-up data of only 3 months. Future studies will need to include patients with follow-up data of 6 months and 12 months to ensure that the streamlined questionnaire remains equally valid throughout the recovery period. In addition, future studies are needed to evaluate the remaining KOOS subscales, as well as perhaps an even more consolidated generalized full KOOS assessment built from these ML-derived mini-subscales. The successful completion of these studies may lead to the development of a mini-KOOS, with a lower question burden but equal fidelity of data. 
